Adefovir anticancer potential: Network pharmacology, anti-proliferative and apoptotic effects in HeLa cells
Biomolecules and Biomedicine · 18.03.2025 · 25 (8) · 1751-1764
DOI: 10.17305/bb.2025.12058 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules and Biomedicine, online erschienen am 18.03.2025. Verfasst von Muzammal Mateen Azhar und 11 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Research in Molecular Medicine, Institute of Molecular Biology and Biotechnology, The University of Lahore, Lahore, Pakistan. Hauptthemen laut MEDLINE: Apoptosis, Organophosphonates, Adenine, Antineoplastic Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cervical cancer presents a significant healthcare challenge due to recurrent disease and drug resistance, highlighting the urgent need for novel therapeutic strategies. Network pharmacology facilitates drug repurposing by elucidating multi-target mechanisms of action. Adefovir, an acyclic nucleotide analog, has shown promising potential in cervical cancer treatment, particularly in HeLa cells. In vitro studies have demonstrated that adefovir inhibits HeLa cell proliferation by enhancing apoptosis while maintaining a low cytotoxicity profile at therapeutic concentrations, making it an attractive candidate for further exploration. A combined network pharmacology and in vitro study was conducted to investigate the molecular mechanism of adefovir against cervical cancer. Potential gene targets for adefovir and cervical cancer were predicted using database analysis. Hub targets were identified, and protein-protein interaction (PPI) networks were constructed. Molecular docking assessed adefovir's binding affinity to key targets. In vitro cytotoxic assays, including 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and crystal violet assays, were performed using 96-well plates to evaluate anti-proliferative effects in HeLa cells. Apoptosis was assessed via p53 immunocytochemistry Enzyme-Linked Immunosorbent Assay (ELISA), while Vascular Endothelial Growth Factor ELISA (VEGF ELISA) was used to measure cell proliferation. Venn analysis identified 144 common targets between adefovir and cervical cancer. Network analysis revealed key hub targets involved in oncogenic pathways. Molecular docking demonstrated strong binding between adefovir and Mitogen-Activated Protein Kinase 3 (MAPK3) and SRC proteins. In vitro, adefovir significantly suppressed HeLa cell viability, with an Inhibitory Concentration 50 (IC50) of 7.8 µM, outperforming 5-Fluorouracil (5-FU). Additionally, it induced apoptosis via p53 activation and inhibited cell proliferation through VEGF suppression. These integrated computational and experimental findings suggest that adefovir exerts multi-targeted effects against cervical cancer. Its promising preclinical efficacy warrants further investigation as a potential alternative therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centre for Research in Molecular Medicine, Institute of Molecular Biology and Biotechnology, The University of Lahore, Lahore, Pakistan.
- Department of Pharmacy, The University of Lahore, Lahore, Pakistan.
- Centre for Research in Molecular Medicine, Institute of Molecular Biology and Biotechnology, The University of Lahore, Lahore, Pakistan; Lahore Medical and Dental College, Lahore, Pakistan.
- Multan Medical and Dental College, Multan, Pakistan.
- Department of Biotechnology, Faculty of Science and Technology, University of Central Punjab, Pakistan.
- Laboratory of Animal Health Food Hygiene and Quality University of Ioannina, Arta, Greece.
Zitieren
APA
Mateen Azhar, M., Maqbool, T., Ali, F., Altaf, A., Atif, M., Ali, Z., Qureshi, Z. H., Naveed, M., Aziz, T., Ali El Hadi Mohamed, R., A Al-Joufi, F., & S Alwethaynani, M. (2025). Adefovir anticancer potential: Network pharmacology, anti-proliferative and apoptotic effects in HeLa cells. Biomolecules and Biomedicine, 25(8), 1751-1764. https://doi.org/10.17305/bb.2025.12058
Vancouver
Mateen Azhar M, Maqbool T, Ali F, Altaf A, Atif M, Ali Z, et al. Adefovir anticancer potential: Network pharmacology, anti-proliferative and apoptotic effects in HeLa cells. Biomolecules and Biomedicine. 2025;25(8):1751-1764. doi:10.17305/bb.2025.12058
BibTeX
@article{MateenAzhar2025,
author = {Mateen Azhar, Muzammal and Maqbool, Tahir and Ali, Fatima and Altaf, Awais and Atif, Muhammad and Ali, Zulfiqar and Qureshi, Zahid Habib and Naveed, Muhammad and Aziz, Tariq and Ali El Hadi Mohamed, Rania and A Al-Joufi, Fakhria and S Alwethaynani, Maher},
title = {Adefovir anticancer potential: Network pharmacology, anti-proliferative and apoptotic effects in HeLa cells},
journal = {Biomolecules and Biomedicine},
year = {2025},
volume = {25},
number = {8},
pages = {1751--1764},
doi = {10.17305/bb.2025.12058}
}
EUVIMED